Jun 26 |
Moderna stock dips on 50% RSV vaccine efficacy after 18 months
|
Jun 26 |
Lilly joins fellow pharma giants in OpenAI partnership
|
Jun 26 |
Moderna RSV Vaccine Efficacy Sinks Over Time, CDC Documents Show
|
Jun 26 |
Sector Update: Health Care Stocks Lower in Afternoon Trading
|
Jun 26 |
Why Is Moderna Stock Trading Lower On Wednesday?
|
Jun 26 |
Moderna shares decline, RSV vaccine efficacy lags behind competitors
|
Jun 26 |
Moderna dips after latest RSV vaccine efficacy data
|
Jun 25 |
Novavax (NVAX) Seeks Nod for Updated COVID-19 Jab in Europe
|
Jun 25 |
Exsilio debuts with $82M, pitching a ‘leap’ forward for genetic medicine
|
Jun 24 |
The FDA awarded a record number of review designations to mRNA vaccines in 2023
|